Compound heart disease tablet for pet

A compound tablet, a technology for heart disease, which is applied in the field of medicine for the treatment of heart disease, can solve the problems of single dosage form of medicine for pets, troublesome taking of animals, etc., and achieve the effects of less adverse drug reactions, convenient taking and rapid disintegration.

Pending Publication Date: 2017-09-22
深圳市众康动保科技有限公司
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In order to solve the technical problems such as the single dosage form of the existing pet drug and troublesome animals to take it, the present invention provides a compound heart disease tablet for treatment and health care for pets with a feasible process and convenient administration, which can meet the current increasingly complicated pet heart problems. disease treatment and healthcare

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound heart disease tablet for pet
  • Compound heart disease tablet for pet

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0009] The present invention will be further explained through specific embodiments below.

[0010] A heart disease compound tablet for pets provided by the present invention is prepared from the following components in mass percent:

[0011] L-carnitine 40-45%, 2-aminoethanesulfonic acid 40-45%, glycine 3-6%, coenzyme Q10 2-5%, calcium pyruvate 0.1-1%,

[0012] Linolenic acid 3-8%, magnesium 0.02-0.03%, potassium 0.1-0.2%, selenium 0.0001-0.0002%, VE 4-6%,

[0013] VB2 0.2- 0.4%, folic acid 0.1- 0.2%.

[0014] According to needs, described compound tablet can be formulated in the different formulations of the following table:

[0015]

[0016] The raw material that the present invention uses has:

[0017] 1. L-carnitine (such as L-carnitine)

[0018] L-carnitine is extremely important for the health of heart muscle cells. Sufficient L-carnitine supplementation is beneficial to the prevention and treatment of many conditions of the heart. Reducing its damage can reduce...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a compound heart disease tablet for a pet. The compound heart disease tablet is prepared from, by mass, 40-45% of L-carnitine, 40-45% of taurine, 3-6% of glycine, 2-5% of coenzyme Q10, 0.1-1% of calcium pyruvate, 3-8% of linolenic acid, 0.02-0.03% of magnesium, 0.1-0.2% of potassium, 0.0001-0.0002% of selenium, 4-6% of VE, 0.2-0.4% of VB2 and 0.1-0.2% of folic acid. The compound heart disease tablet is smooth in appearance and rapid to disintegrate, and various indexes of the tablet are optimized. The compound tablet has the advantages of being high in treating effect and convenient to take, producing few adverse drug reactions and the like, missed taking is easy to avoid in daily prevention and control work, and the medication rationality is guaranteed. In addition, after the compound table is mixed with natural beef bone marrow extract, so that the tablet is has a beef flavor, is suitable for cats and dogs to eat and is simple in process, feasible, low in cost and suitable for industrial production.

Description

technical field [0001] The invention relates to a medicine for treating heart disease, in particular to a heart disease compound tablet for pets. Background technique [0002] With the development of pet medical technology and the continuous improvement of people's living standards, the proportion of pet geriatric diseases is increasing day by day. Heart disease is a common disease for many elderly pets. At present, there is no heart compound preparation suitable for pets in China. Pets need to be treated with a combination of drugs every time, and several drugs are used at the same time, which increases the pain of pets and the burden on the owner. Moreover, it takes a long time for each new drug to go through from the start of research to the final registration and marketing. On the basis of the original drugs, developing various formulations and using existing drugs and new technologies to prepare compound preparations is a research direction for the development of new d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/06A61K9/20A61K47/46A61P9/00A61K33/04A61K33/00A61K31/525A61K31/519A61K31/355A61K31/205A61K31/202A61K31/198A61K31/19A61K31/185A61K31/122
CPCA61K33/06A61K9/2068A61K31/122A61K31/185A61K31/19A61K31/198A61K31/202A61K31/205A61K31/355A61K31/519A61K31/525A61K33/00A61K33/04A61K2300/00
Inventor 方晶
Owner 深圳市众康动保科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap